
Loading, please wait...

Loading, please wait...

Oligonucleotide therapeutics represent a transformative frontier in modern medicine, especially for targeting disease-associated RNAs. Consequently, maintaining rigorous oligonucleotide therapeutic quality control is essential to ensure consistent drug performance and patient safety. Phosphorothioate (PS) modifications are central to these therapies because they enhance metabolic stability. However, current manufacturing practices produce a complex mixture of stereoisomers. Because these variations can influence clinical efficacy, scientists must employ sensitive analytical tools to monitor the final product.
A recent study evaluated several techniques to determine their sensitivity to diastereomer distribution. While ultraviolet (UV) and circular dichroism (CD) offered limited insights, nuclear magnetic resonance (NMR) spectroscopy proved highly effective. Specifically, applying principal component analysis (PCA) to NMR spectra allowed researchers to identify subtle changes linked to manufacturing activators. Therefore, this high-resolution evaluation highlights the necessity of advanced technology in ensuring batch consistency. Manufacturers must prioritize stereochemical purity to guarantee predictable pharmacodynamic properties. Consequently, advanced NMR protocols provide a robust pathway for regulatory compliance and product reliability. Furthermore, this research underscores that simple univariate metrics often fail to capture the full complexity of synthetic oligonucleotides. Thus, adopting multivariate analysis will likely become a standard in the development of next-generation genetic therapies.
The arrangement of atoms, or stereochemistry, affects how the drug interacts with target RNA and its overall stability. Variations in stereoisomers can lead to differences in how well the drug works for the patient.
NMR spectroscopy provides a detailed molecular fingerprint. When researchers combine it with principal component analysis, it detects tiny structural variations that other methods might miss.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always consult a qualified healthcare professional for medical concerns. Refer to the latest local and national guidelines for clinical practice.
References
Manghrani A et al. Unraveling the Stereochemical Complexity of Phosphorothioate-Modified Oligonucleotides Using Analytical Technologies. Nucleic Acid Ther. 2026 May 27. doi: 10.1177/21593337261452594. PMID: 42200337.
Bruker. NMR characterization of oligonucleotides and peptides. [Online]. Available from: https://www.bruker.com/en/products-and-solutions/mr/nmr-pharma/nmr-characterization-of-oligonucleotides-and-peptides.html
Assay Genie. Phosphorothioate: Enhancing Stability in Oligonucleotide-Based Therapies. [Online]. Available from: https://www.assaygenie.com/blog/phosphorothioate-enhancing-stability-in-oligonucleotide-based-therapies/

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


NMR spectroscopy combined with PCA outperforms traditional UV and CD methods in detecting stereoisomer variations in PS-modified oligonucleotide drugs....
3 months ago

A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today